Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP335446.RA-uZvMJXYbaKWr-8fkGaermlWGNMsONOcKGpUASPEf4U130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP335446.RA-uZvMJXYbaKWr-8fkGaermlWGNMsONOcKGpUASPEf4U130_assertion type Assertion NP335446.RA-uZvMJXYbaKWr-8fkGaermlWGNMsONOcKGpUASPEf4U130_head.
- NP335446.RA-uZvMJXYbaKWr-8fkGaermlWGNMsONOcKGpUASPEf4U130_assertion description "[To the best of our knowledge, this is the first prospective analysis in which the prognostic impact of a relatively high number of antigenic markers has been simultaneously analyzed in a large series of uniformly treated patients, showing that the expression of several antigens (particularly CD28 and CD117) on bone marrow plasma cells from patients with MM can help to identify patients at high risk of progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP335446.RA-uZvMJXYbaKWr-8fkGaermlWGNMsONOcKGpUASPEf4U130_provenance.
- NP335446.RA-uZvMJXYbaKWr-8fkGaermlWGNMsONOcKGpUASPEf4U130_assertion evidence source_evidence_literature NP335446.RA-uZvMJXYbaKWr-8fkGaermlWGNMsONOcKGpUASPEf4U130_provenance.
- NP335446.RA-uZvMJXYbaKWr-8fkGaermlWGNMsONOcKGpUASPEf4U130_assertion SIO_000772 18443352 NP335446.RA-uZvMJXYbaKWr-8fkGaermlWGNMsONOcKGpUASPEf4U130_provenance.
- NP335446.RA-uZvMJXYbaKWr-8fkGaermlWGNMsONOcKGpUASPEf4U130_assertion wasDerivedFrom befree-20150227 NP335446.RA-uZvMJXYbaKWr-8fkGaermlWGNMsONOcKGpUASPEf4U130_provenance.
- NP335446.RA-uZvMJXYbaKWr-8fkGaermlWGNMsONOcKGpUASPEf4U130_assertion wasGeneratedBy ECO_0000203 NP335446.RA-uZvMJXYbaKWr-8fkGaermlWGNMsONOcKGpUASPEf4U130_provenance.